Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q2 2020 · 10-Q
Revenue$69.94M$69.94M−2.0% vs Q2 2019 Net Income$6.67M$6.67M−38.0% vs Q2 2019 EPS Diluted$0.33$0.33−36.5% vs Q2 2019 Gross Profit$20,002,000−20.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$17,258,000N/M Free Cash Flowderived$17,034,000N/M Margins · derivedGross margin28.6%−6.8 pt vs Q2 2019
Operating margin12.0%−6.5 pt vs Q2 2019
Net margin9.5%−5.5 pt vs Q2 2019
ended Sep 30, 2019 · filed Oct 30, 2019 · 30 d after period end